Cite
HARVARD Citation
Ishigami, J. et al. (2022). 18-year change in serum intact fibroblast growth factor 23 from midlife to late life and risk of mortality: the ARIC Study. European journal of endocrinology. 187 (1), pp. 39-47. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ishigami, J. et al. (2022). 18-year change in serum intact fibroblast growth factor 23 from midlife to late life and risk of mortality: the ARIC Study. European journal of endocrinology. 187 (1), pp. 39-47. [Online].